TY - JOUR
T1 - Aspirin, warfarin and a thienopyridine for acute coronary syndromes
AU - Konstantino, Yuval
AU - Iakobishvili, Zaza
AU - Porter, Avital
AU - Sandach, Amir
AU - Zahger, Doron
AU - Hod, Hanoch
AU - Hammerman, Haim
AU - Gottlieb, Shmuel
AU - Behar, Solomon
AU - Hasdai, David
PY - 2006/2
Y1 - 2006/2
N2 - Background: Although clopidogrel and aspirin (dual therapy, DT) are used for acute coronary syndrome (ACS), sometimes treatment with warfarin (triple therapy, TT) is required. Aim: To determine the incidence, complications, and outcomes of TT. Methods: We analyzed Israeli surveys of ACS from 2000 to 2004. Results: In these surveys, 5,706 (96%) were discharged alive from hospital. Post-ACS TT and DT were 76 patients (1.3%) and 2,661 patients (46.7%), respectively. The TT group was older with more prior cardiac disease. During hospitalization, the TT patients received more intravenous anticoagulant and antithrombotic agents, and had more heart failure, arrhythmias, ischemia, and major bleeding (2.6 vs. 0.6%, p = 0.03). There were no differences in adjusted 30-day and 6-month mortality between the 2 groups. Conclusion: TT is feasible among ACS patients who require concomitant warfarin treatment.
AB - Background: Although clopidogrel and aspirin (dual therapy, DT) are used for acute coronary syndrome (ACS), sometimes treatment with warfarin (triple therapy, TT) is required. Aim: To determine the incidence, complications, and outcomes of TT. Methods: We analyzed Israeli surveys of ACS from 2000 to 2004. Results: In these surveys, 5,706 (96%) were discharged alive from hospital. Post-ACS TT and DT were 76 patients (1.3%) and 2,661 patients (46.7%), respectively. The TT group was older with more prior cardiac disease. During hospitalization, the TT patients received more intravenous anticoagulant and antithrombotic agents, and had more heart failure, arrhythmias, ischemia, and major bleeding (2.6 vs. 0.6%, p = 0.03). There were no differences in adjusted 30-day and 6-month mortality between the 2 groups. Conclusion: TT is feasible among ACS patients who require concomitant warfarin treatment.
KW - Acute coronary syndromes
KW - Aspirin
KW - Bleeding
KW - Clopidogrel
KW - Mortality
KW - Warfarin
UR - http://www.scopus.com/inward/record.url?scp=31944437929&partnerID=8YFLogxK
U2 - 10.1159/000089548
DO - 10.1159/000089548
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:31944437929
SN - 0008-6312
VL - 105
SP - 80
EP - 85
JO - Cardiology
JF - Cardiology
IS - 2
ER -
